1. Pfizer buying Array Biopharma for $11.4B — AstraZeneca commits $630M to Korean drug R&D push — AstraZeneca’s Lokelma shows significant effect in ESRD trial -- See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Dealing with a potential legal issue at work?Ask an Employment Attorney -- a chance to discuss employment-related legal issues with a practicing attorney with over 20 years in employment law experience.
    Dismiss Notice

Better than CAR-T? Already prepping for a US launch, MorphoSys posts stellar DLBCL data to...

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, May 17, 2019 at 1:12 PM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    10,768
    Likes Received:
    3
    via Already beavering away at building a US commercial operation, MorphoSys {$MOR} is now bearing down on Novartis and Gilead with a potential CAR-T killer soon to be put into the hands of US regulators.

    article source